Literature DB >> 5452310

Renin relationships in congestive cardiac failure, treated and untreated.

J J Brown, D L Davies, V W Johnson, A F Lever, J I Robertson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 5452310     DOI： 10.1016/0002-8703(70)90098-0

Source DB:  PubMed          Journal:  Am Heart J        ISSN： 0002-8703            Impact factor:   4.749


× No keyword cloud information.
  45 in total

Review 1.  Diuretics: mechanism of action and clinical application.

Authors:  D L Davies; G M Wilson
Journal:  Drugs       Date:  1975       Impact factor: 9.546

2.  Prediction of renal impairment in elderly patients with congestive heart failure treated with captopril.

Authors:  D Schwartz; R Kornowski; I F Schwartz; I Dotan; B Weinreb; M Averbuch; Y Golan; Y Levo; A Iaina
Journal:  Cardiovasc Drugs Ther       Date:  1996-03       Impact factor: 3.727

3.  [Regulation of the renin-angiotensin system in congestive heart failure: indications for a total body sodium-dependent regulation of the renin secretion].

Authors:  D K Krause; E Rosskamp; K A Meurer; W Kaufmann
Journal:  Klin Wochenschr       Date:  1972-03-15

4.  [Effect of dopamine on hemodynamics and renal function in patients with severe congestive heart failure].

Authors:  B Ramdohr; K P Schüren; G Biamino; R Schröder
Journal:  Klin Wochenschr       Date:  1973-06-01

5.  The effect of treatment of congestive heart failure on plasma atrial natriuretic peptide concentration: a longitudinal study.

Authors:  J V Anderson; P W Woodruff; S R Bloom
Journal:  Br Heart J       Date:  1988-02

Review 6.  Neurohormonal mechanisms and the role of angiotensin-converting enzyme (ACE) inhibitors in heart failure.

Authors:  A J Coats; S Adamopoulos
Journal:  Cardiovasc Drugs Ther       Date:  1994-10       Impact factor: 3.727

7.  Captopril in heart failure. A double blind controlled trial.

Authors:  J G Cleland; H J Dargie; G P Hodsman; S G Ball; J I Robertson; J J Morton; B W East; I Robertson; G D Murray; G Gillen
Journal:  Br Heart J       Date:  1984-11

8.  Renal effects of xamoterol in patients with moderate heart failure.

Authors:  H E Bøtker; H K Jensen; L R Krusell; E V Sørensen
Journal:  Cardiovasc Drugs Ther       Date:  1993-02       Impact factor: 3.727

Review 9.  Long-range safety and protective benefits of angiotensin-converting enzyme inhibitors for hypertension. Do we need more clinical trials?

Authors:  M P Sambhi; H Gavras; J I Robertson; W M Smith
Journal:  West J Med       Date:  1993-03

10.  Studies on the activity of the renin-angiotensin-aldosterone system (RAAS) in patients with cirrhosis of the liver.

Authors:  H Wernze; H J Spech; G Müller
Journal:  Klin Wochenschr       Date:  1978-04-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.